SAGE

Sage Therapeutics, Inc. - Common Stock

$163.86 +$0.68 +0.41%



Shares Bought4
Shares Sold4
Total8
Shares Owned0
Last Price$163.86
Total Return-$40.98
Range Today$161.18 - $171.38
52 Week Range$59.57 - $195.97
Open$161.18
Market Cap$6.15B
Volume/Average281.89K/608.59K
P/E Ratio-
Dividend/Yield-




SAGE Therapeutics, Inc. is a clinical stage biopharmaceutical company. The company engages in the development and commercialization of novel medicines to treat central nervous system disorders. Its product candidate includes SAGE-547, which is in clinical development for super-refractory status epileptics; SAGE-217; and SAGE-689, which are in IND-enabling toxicology and safety pharmacology testing. The company was founded by Steven Marc Paul and Douglas Covey in April 2010 and is headquartered in Cambridge, MA.


Wallet Positions

Buy Date Buy Price Quote Return $ Return % Owners

Open Positions

Buy Date Buy Price Quote Return $ Return % Owners

Closed Positions

Buy Date Sell Date Buy Price Sell Price Return $ Return % Owners
18-02-13 15:01 18-02-15 21:43 $161.91 $163.40 +$1.49 +0.92% numbtwitch
18-02-06 19:24 18-02-12 14:06 $176.63 $154.55 -$22.08 -12.50% numbtwitch
18-02-13 14:53 18-02-15 21:31 $161.98 $163.40 +$1.42 +0.88% numbtwitch
18-02-06 19:20 18-02-12 14:04 $176.36 $154.55 -$21.81 -12.37% numbtwitch